Category: 4. Health

The PainWaive technology, developed by UNSW Sydney researchers, teaches users how to regulate abnormal brain activity linked to chronic nerve pain, offering a potential in-home, non-invasive alternative to opioids.

A recent trial of the technology, led by Professor Sylvia Gustin and Dr Negin Hesam-Shariati…

University of Virginia School of Medicine scientists have been investigating the possibility that Alzheimer’s is caused, at least in part, by the immune system’s wayward attempts to fix DNA damage in the brain. Their research reveals that an immune molecule called STING drives the formation of the harmful…

A team of University of Texas at Dallas researchers and their colleagues have discovered that the mixing of small particles between two solid electrolytes can generate an effect called a “space charge layer,” an accumulation of electric charge at the interface between the…

Extreme water levels — like the 15 feet of flooding Floridians saw during Hurricane Helene in 2024 — threaten lives, wash away homes, and damage ecosystems. But they can be difficult to predict without complex, data-intensive computer models that areas with limited resources…

Corinne Hazel, of Delaware, Ohio, an environmental microbiology major and Goldwater Scholar, discovered the new species of fungus growing in morning glory…

This week in Microbiology Spectrum, researchers describe a newly synthesized compound called infuzide that shows activity…

The collaborative study led by researchers at RMIT University in Australia is the first reported use of antibacterial coatings made from resilin-mimetic proteins to fully block bacteria from attaching to a surface.

Study lead author Professor Namita Roy Choudhury said the finding is a critical step towards their…

Set to launch this month, a recently approved blood test to detect biomarkers for Alzheimer’s disease could bring diagnosis into everyday clinical practice. In turn, this may support earlier intervention approaches that may help patients, their families and caregivers. The diagnostic, called a Lumipulse G Plasma Ratio test, is the first of its kind to get marketing clearance from the Food and Drug Administration. Until now,…

For the first time, we are witnessing therapies that can fundamentally alter the course of inherited disease lifelong. The most recent breakthrough describes treating inherited disease in infants. In a case in Nature Medicine, a…

The recent announcement that Teva Pharmaceuticals will lay off roughly 2,400 employees–approximately 8% of its global workforce–is a significant development in a sector already under strain. This move aims to save $700 million by 2027 as Teva attempts to rebalance its role as both a generics manufacturer…